Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019
- PMID: 32649747
- PMCID: PMC7454444
- DOI: 10.1093/cid/ciaa964
Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019
Abstract
Hospitalized patients with coronavirus disease 2019 (COVID-19) experiencing respiratory symptoms have different complications (inflammatory, co-infection, and thrombotic) that are identifiable by analytics patterns. Personalized treatment decisions decreased early mortality (odds ratio [OR] .144; 95% confidence interval [CI] .03-.686; P = .015). Increasing age (OR 1.06; P = .038) and therapeutic effort limitation (OR 9.684; P < .001) were associated with higher mortality.
Keywords: COVID-19; patterns; personalized therapy; pneumonia.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Comment in
-
Treatment of Coronavirus Disease 2019-Evidence-based or Personalized Medicine?Clin Infect Dis. 2022 Jan 7;74(1):149-151. doi: 10.1093/cid/ciaa996. Clin Infect Dis. 2022. PMID: 32667978 Free PMC article. No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources